2019

According to research funded by the FDA and published last month, participants in a study on direct-to-consumer (DTC) advertising…

On April 9th, the U.S. Department of Justice (DOJ) announced that a federal grand jury returned a 28-count criminal indictment…

On April 18, 2019, President Trump signed H.R. 1839—Medicaid Services Investment and Accountability Act of 2019—into law.  The new…

A new Congressional Budget Office report Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid finds that net…

Recently the FDA issued final guidance on FDA’s application of the statutory factors in determining when a risk evaluation and…

On April 2, 2019, the Senate Committee on Aging held a hearing to look at innovations being made in Alzheimer’s research and care…

Telemedicine has long been discussed as a possibility of where our healthcare future lies: the ability to log into your computer…

After several years, the Maine Board of Pharmacy issued its Notice of Agency Rule-making Proposal related to its gift ban law that…

We frequently hear the buzz word “AI” (artificial intelligence), usually coupled with how it’s coming for our jobs and how…

In response to reports questioning the FDA’s inspections and oversight of generic drugs, FDA Commissioner Scott Gottlieb and…